Critical role of class IA PI3K for c-Rel expression in B lymphocytes

Blood

Volumn 113, Issue 5, 2009, Pages 1037-1044

  Matsuda, Satoshi ^a,b   Mikami, Yohei ^a   Ohtani, Masashi ^a,b   Fujiwara, Mari ^a,b   Hirata, Yasuko ^a,b   Minowa, Akiko ^a,b   Terauchi, Yasuo ^b,c   Kadowaki, Takashi ^b,c   Koyasu, Shigeo ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; BRUTON TYROSINE KINASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE IA; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; XID PROTEIN; AGAMMAGLOBULINAEMIA TYROSINE KINASE; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE KINASE; RELA PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; LENTIVIRINAE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; ENZYME STABILITY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; B-LYMPHOCYTES; CELL NUCLEUS; ENZYME STABILITY; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MUTATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 60849117518     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-06-163725     Document Type: Article

References (47)

1. -KB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225-260.
2. -KB activity. Annu Rev Immunol. 2000;18:621-663.
3. -KB puzzle. Cell. 2002;109:S81-96.
4. -KB regulation in the immune system. Nat Rev Immunol. 2002;2:725-734.
5. -KB transcription factors: key mediators of B-cell activation. Immunol Rev. 2000;176:134-140.
6. -KB. Nat Rev Immunol. 2005;5:435-445.
7. -KB in osteoclast and B-cell development. Genes Dev. 1997;11:3482-3496.
8. -KB is required for the development of marginal zone B lymphocytes. J Exp Med. 2000;192:1175-1182.
9. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S. The antiapoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 2000;19:6351-6360.
10. -KB kinase signaling is essential for maintenance of mature B cells. J Exp Med. 2002;196:743-752.
11. Koyasu S. The role of PI3K in immune cells. Nat Immunol. 2003;4:313-319.
12. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci. 2005;30:194-204.
13. Suzuki H, Terauchi Y, Fujiwara M, et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science. 1999;283:390-392.
14. Fruman DA, Satterthwaite AB, Witte ON. Xid-like phenotypes: a B cell signalosome takes shape. Immunity. 2000;13:1-3.
15. Kurosaki T, Tsukada S. BLNK: connecting Syk and Btk to calcium signals. Immunity. 2000;12: 1-5.
16. -KB kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol. 2002;3: 780-786.
17. -KB activation. J Exp Med. 2000;191:1735-1744.
18. -KB in response to B cell receptor engagement. J Exp Med. 2000; 191:1745-1754.
19. Suzuki H, Matsuda S, Terauchi Y, et al. PI3K and Btk differentially regulate B cell antigen receptormediated signal transduction. Nat Immunol. 2003;4:280-286.
20. -KB regulated c-myc transcription. Mol Cell. 2002;10: 1283-1294.
21. Satterthwaite AB, Li Z, Witte ON. Btk function in B cell development and response. Semin Immunol. 1998;10:309-316.
22. Baba Y, Nonoyama S, Matsushita M, et al. Involvement of wiskott-aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood. 1999;93:2003-2012.
23. Druker BJ, Mamon HJ, Roberts TM. Oncogenes, growth factors, and signal transduction. N Engl J Med. 1989;321:1383-1391.
24. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol. 1998;72:8150-8157.
25. Futatani T, Miyawaki T, Tsukada S, et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood. 1998;91:595-602.
26. Gregersen N, Bolund L, Bross P. Protein misfolding, aggregation, and degradation in disease. Mol Biotechnol. 2005;31:141-150.
27. Matsuda S, Suzuki-Fujimoto T, Minowa A, Ueno H, Katamura K, Koyasu S. Temperature-sensitive ZAP70 mutants degrading through a proteasome-independent pathway: restoration of a kinase domain mutant by Cdc37. J Biol Chem. 1999;274:34515-34518.
28. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol. 2001;167:6834-6840.
29. Loder F, Mutschler B, Ray RJ, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med. 1999;190: 75-89.
30. Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol. 2002;168: 2101-2110.
31. Jun JE, Wilson LE, Vinuesa CG, et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity. 2003;18:751-762.
32. Hara H, Wada T, Bakal C, et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity. 2003;18:763-775.
33. Xue L, Morris SW, Orihuela C, et al. Defective development and function of Bc110-deficient follicular, marginal zone and B1 B cells. Nat Immunol. 2003;4:857-865.
34. -KB-dependent lymphocyte activation and development by paracaspase. Science. 2003;302:1581-1584.
35. Donahue AC, Hess KL, Ng KL, Fruman DA. Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85α. Int Immunol. 2004;16:1789-1798.
36. Oh-hora M, Johmura S, Hashimoto A, Hikida M, Kurosaki T. Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase cΓ2 to Ras in B cell receptor signaling. J Exp Med. 2003;198:1841-1851.
37. Kang SW, Wahl MI, Chu J, et al. PKCβ modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 2001;20:5692-5702.
38. Köntgen F, Grumont RJ, Strasser A, et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995;9: 1965-1977.
39. Rolink AG, Andersson J, Melchers F. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol. 1998;28:3738-3748.
40. Sandel PC, Monroe JG. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity. 1999;10:289-299.
41. Vá rnai P, Bondeva T, Tamas P, et al. Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell Sci. 2005;118:4879-4888.
42. Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell. 2004;117:787-800.
43. Glassford J, Soeiro I, Skarell SM, et al. BCR targets cyclin D2 via Btk and the p85α subunit of PI3K to induce cell cycle progression in primary mouse B cells. Oncogene. 2003;22:2248-2259.
44. Yamazaki T, Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat Immunol. 2003;4:780-786.
45. Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA. Optimal B cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood. 2004;104:784-787.
46. Reif K, Okkenhaug K, Sasaki T, et al. Cutting edge: differential roles for phosphoinositide 3-kinases, p110γand p110β, in lymphocyte chemotaxis and homing. J Immunol. 2004;173:2236-2240.
47. Vanhaesebroeck B, Jones GE, Allen WE, et al. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol. 1999;1:69-71.